On June 4, IBM fell 3.06% in pre-market trading, trading at approximately $296.82/share, with trading volume of $10.51 million. The stock continued its pullback following a 7.17% decline in the prior session.
The decline reflects sustained profit-taking pressure after IBM accumulated approximately 40% gains since May. The prior session saw quantum computing stocks broadly sell off, with Rigetti Computing down 10.36%, D-Wave Quantum down 7.89%, and IonQ down 4.44%. Macro headwinds including rising oil prices driven by US-Iran tensions and climbing US Treasury yields further weighed on risk appetite.
Despite multiple analyst upgrades — Wedbush Securities raised its target to $350 reiterating an Outperform rating, and Citigroup lifted its target from $285 to $375 — the magnitude of prior gains prompted concentrated profit-taking by long-positioned investors. On the fundamental front, IBM has committed over $100 billion in quantum computing investment over five years, secured approximately $1 billion in US Commerce Department funding for its Anderon quantum chip fabrication venture, and completed a $11 billion acquisition of Confluent to build its data moat.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments